SynthesisImmunity, inflammation and disease2021

Efficacy and safety of arbidol (umifenovir) in patients with COVID-19: A systematic review and meta-analysis.

Behnam Amani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.